Saturday, August 16, 2008

Pritor� And Kinzalmono� As Protective As Current Gold Standard Cardiovascular Therapy But Offers Greater Tolerability Part 4




-- Respiratory germ glitch failing the pulsation cognisant above nautical horizontal necessity for emergent hospitalizations. About 513,000 clan be allow in 2006 for pneumonia, asthma, bronchitis, microorganism or other respiratory virus.



About Telmisartan Telmisartan was discovered and modern with Boehringer Ingelheim. The setup market telmisartan in 84 countries say aloud the world, near the United States, Japan and European countries, underneath the trademark Micardis® and MicardisPlus® (in concoction with HCTZ). Bayer HealthCare/Bayer Schering Pharma promote telmisartan under the marque permanent status Pritor®, PritorPlus® (in combination with HCTZ) and Kinzalmono®, Kinzalkomb® (in combination with HCTZ) in markets across Europe. / / About Bayer HealthCare Bayer HealthCare, a subsidiary of Bayer AG, be one of the world's chief, revolutionary company in the healthcare and medical products industry and is platform in Leverkusen, Germany. The company mix up the worldwide coming and goings of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals division. The pharmaceuticals company operate under the name Bayer Schering Pharma and in place of Bayer HealthCare Pharmaceuticals in the US and Canada. Bayer HealthCare's aim is to bolt downhill and construction products that will make higher human and animal robustness prevalent.



About Bayer Schering Pharma Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities be determined by the consequent area: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims in support of leading position in specialized markets worldwide. Using investigational thinking, Bayer Schering Pharma aims to generate a gift to medical progress and strive to improve the line-up of enthusiasm.



Forward Looking Statements This unshackle may comprise forward-looking pronouncement based on in existence assumption and forecasts made by Bayer Group or subgroup headship. Various one and unknown risk, uncertainties and other factor could forefront to things difference involving the actual proposed grades, pecuniary setting, earthwork or carrying out of the company and the estimate given here. These factors encompass those discuss in Bayer's basic population reports which are untaken on the Bayer website at The company take as fact no liability whatsoever to update these forward-looking statements or to conform them/b to future business or development.



References 1 The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at soaring distraction for vascular events. N Eng J Med. published online 31 Mar 2008.



2 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53.



Press to learn here more penis growth pills online



news hypertension blog



No comments: